Cdk phosphorylation of Chk1 regulates efficient Chk1 activation and multiple checkpoint proficiency

被引:6
|
作者
Xu, Naihan [1 ,2 ]
Libertini, Silvana [2 ]
Zhang, Yaou [1 ]
Gillespie, David A. [2 ,3 ]
机构
[1] Tsinghua Univ, Grad Sch Shenzhen, Div Life Sci, Shenzhen 518055, Peoples R China
[2] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland
[3] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland
关键词
Chk1; Cdk; S/M checkpoint; G2/M checkpoint; Cell cycle; DOUBLE-STRAND BREAKS; DNA-DAMAGE; S-PHASE; RECRUITMENT; SURVIVAL; REPAIR; CELLS; ATR;
D O I
10.1016/j.bbrc.2011.08.119
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It has been reported previously that both Cdk1 and Cdk2 phosphorylate Chk1 in a cell-cycle dependent manner. Cdk-mediated phosphorylation is required for efficient activation of Chk1 and checkpoint proficiency in response to DNA damage. Here, we demonstrate that Cdk-mediated phosphorylation is also required for replication stress induced Chk1 activation and S/M checkpoint proficiency. Re-introduction of Chk1 mutant (S286A/S301A) into Chk1 deficient cells is capable of restraining mitosis in cells with completely unreplicated DNA, but the mitotic delay at later stage of the cell cycle is largely impaired. The mutation strongly attenuates aphidicolin induced Chk1 activation without altering the S-phase dependent Chk1 activation. These data indicate that Cdk-mediated phosphorytion is required for efficient Chk1 activation and multiple checkpoint proficiency. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:465 / 470
页数:6
相关论文
共 50 条
  • [41] A novel function of HGF in the activation of Chk1 phosphorylation in colon cancer cells
    Song, Na
    Che, Xiaofang
    Qu, Xiujuan
    Xu, Lu
    Hou, Kezuo
    Liu, Yunpeng
    CANCER RESEARCH, 2017, 77
  • [42] A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation
    Zhan Xiao
    John Xue
    Thomas J Sowin
    Saul H Rosenberg
    Haiying Zhang
    Oncogene, 2005, 24 : 1403 - 1411
  • [43] γH2AX and Chk1 phosphorylation as predictive pharmacodynamic biomarkers of Chk1 inhibitor-chemotherapy combination treatments
    Rebecca Rawlinson
    Andrew J Massey
    BMC Cancer, 14
  • [44] Cytoplasmic occurrence of the Chk1/Cdc25 pathway and regulation of Chk1 in Xenopus oocytes
    Oe, T
    Nakajo, N
    Katsuragi, Y
    Okazaki, K
    Sagata, N
    DEVELOPMENTAL BIOLOGY, 2001, 229 (01) : 250 - 261
  • [45] A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation
    Xiao, Z
    Xue, J
    Sowin, TJ
    Rosenberg, SH
    Zhang, HY
    ONCOGENE, 2005, 24 (08) : 1403 - 1411
  • [46] Lethal Errors in Checkpoint Control Life without Chk1
    Zachos, George
    Rainey, Michael
    Gillespie, David A. F.
    CELL CYCLE, 2003, 2 (01) : 14 - U37
  • [47] γH2AX and Chk1 phosphorylation as predictive pharmacodynamic biomarkers of Chk1 inhibitor-chemotherapy combination treatments
    Rawlinson, Rebecca
    Massey, Andrew J.
    BMC CANCER, 2014, 14
  • [48] Targeting the replication checkpoint with a potent and selective CHK1 inhibitor
    Parry, David
    Shanahan, Frances
    Davis, Nicole
    Wiswell, Derek
    Seghezzi, Wolfgang
    Pierce, Robert
    Hsieh, Yunsheng
    Paruch, Kamil
    Guzi, Timothy
    CANCER RESEARCH, 2009, 69
  • [49] And-1 coordinates with Claspin for efficient Chk1 activation in response to replication stress
    Hao, Jing
    de Renty, Christelle
    Li, Yongming
    Xiao, Haijie
    Kemp, Michael G.
    Han, Zhiyong
    DePamphilis, Melvin L.
    Zhu, Wenge
    EMBO JOURNAL, 2015, 34 (15): : 2096 - 2110
  • [50] The DNA repair component Metnase regulates Chk1 stability
    Williamson, Elizabeth A.
    Wu, Yuehan
    Singh, Sudha
    Byrne, Michael
    Wray, Justin
    Lee, Suk-Hee
    Nickoloff, Jac A.
    Hromas, Robert
    CELL DIVISION, 2014, 9